We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+13.49%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$15.1B
AUM Growth
+$367M
Cap. Flow
-$1.2B
Cap. Flow %
-7.98%
Top 10 Hldgs %
15.48%
Holding
700
New
227
Increased
111
Reduced
135
Closed
190

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$220M
2
EL icon
Estee Lauder
EL
+$166M
3
ADSK icon
Autodesk
ADSK
+$153M
4
TXN icon
Texas Instruments
TXN
+$140M
5
DELL icon
Dell
DELL
+$134M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Consumer Discretionary 14.27%
3 Healthcare 14.13%
4 Industrials 12.15%
5 Financials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTM
676
ZoomInfo Technologies
GTM
$1.25B
-2,096,940
Closed -$34.4M
SOC icon
677
CALL
Sable Offshore Corp
SOC
$951M
-800,000
Closed -$8.37M
ENFN
678
DELISTED
Enfusion, Inc.
ENFN
-375,000
Closed -$3.36M
HCP
679
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-1,355,686
Closed -$31M
ROIC
680
DELISTED
Retail Opportunity Investments Corp.
ROIC
-1,125,120
Closed -$13.9M
ENLC
681
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
-194,283
Closed -$2.37M
SMAR
682
DELISTED
Smartsheet Inc.
SMAR
-923,792
Closed -$37.4M
NAPA
683
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
-650,500
Closed -$6.67M
CTLT
684
DELISTED
CATALENT, INC.
CTLT
-300,000
Closed -$13.7M
LILM
685
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
-4,362,667
Closed -$3.97M
PRFT
686
DELISTED
Perficient Inc
PRFT
-402,960
Closed -$23.3M
MMAT
687
CALL
DELISTED
Meta Materials Inc. Common Stock
MMAT
-60,000
Closed -$1.27M
SBOW
688
DELISTED
SilverBow Resources, Inc.
SBOW
-382,809
Closed -$13.7M
BHIL
689
DELISTED
Benson Hill, Inc.
BHIL
-32,857
Closed -$293K
GETR
690
DELISTED
Getaround, Inc.
GETR
-325,000
Closed -$113K
PXD
691
DELISTED
Pioneer Natural Resource Co.
PXD
-375,830
Closed -$86.3M
AYX
692
DELISTED
Alteryx Inc
AYX
-990,292
Closed -$37.3M
MDRX
693
DELISTED
Veradigm Inc. Common Stock
MDRX
-1,078,413
Closed -$14.2M
RYZB
694
DELISTED
RayzeBio, Inc. Common Stock
RYZB
-25,000
Closed -$555K
NSTG
695
DELISTED
NanoString Technologies, Inc.
NSTG
-671,515
Closed -$1.16M
IMGN
696
DELISTED
Immunogen Inc
IMGN
-150,000
Closed -$2.38M
VAPO
697
DELISTED
Vapotherm, Inc. Common Stock
VAPO
-22,811
Closed -$57.7K
PACW
698
DELISTED
PacWest Bancorp
PACW
-654,807
Closed -$5.18M
EVLO
699
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-265,103
Closed -$1.04M
BIOC
700
DELISTED
Biocept, Inc.
BIOC
-117,647
Closed -$147K

Similar funds

Alyeska Investment Group's Q4 2023 Portfolio in Review

As of Q4 2023, Alyeska Investment Group held 700 positions worth $15.1B, up 2.5% from $14.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group withdrew a net $1.2B in Q4 2023, closing 190 positions and reducing 135 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Alyeska Investment Group opened a new position in Estee Lauder worth $183M.

  • Alyeska Investment Group's largest Q4 2023 buy was Estee Lauder: 1,254,443 shares worth $183M.
  • Alyeska Investment Group added most to Meta Platforms (Facebook) in Q4 2023, an estimated $220M increase.
  • Alyeska Investment Group's biggest Q4 2023 reduction was Boeing, cutting an estimated $192M.
  • Alyeska Investment Group fully exited Alphabet (Google) Class A in Q4 2023, selling an estimated $187M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $15.1B portfolio in Q4 2023.
  • Alyeska Investment Group opened 227 new positions and closed 190 in Q4 2023.
  • Alyeska Investment Group's portfolio value rose 2.5% quarter-over-quarter to $15.1B.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.